PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma.
<h4>Background</h4>Pancreatic adenocarcinoma (PDAC) is an incurable cancer without adequate tumor markers. Our previous study has showed a better diagnostic performance of Protein Induced by Vitamin K Absence II (PIVKA-II) compared to currently used PDAC biomarkers. To corroborate our pr...
Guardado en:
Autores principales: | Sara Tartaglione, Patrizia Mancini, Valentina Viggiani, Piero Chirletti, Antonio Angeloni, Emanuela Anastasi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5f3204e490b4ed8aaa3767eeeae8722 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dynamic perfusion CT – A promising tool to diagnose pancreatic ductal adenocarcinoma
por: Zaborienė Inga, et al.
Publicado: (2021) -
Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma.
por: Yasheen Gao, et al.
Publicado: (2021) -
Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?
por: Monika Kapszewicz, et al.
Publicado: (2021) -
Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma
por: Cheng-Wei Chou, et al.
Publicado: (2021) -
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
por: Michelle R. Goulart, et al.
Publicado: (2021)